Baciewicz A M, Self T H, Bekemeyer W B
Arch Intern Med. 1987 Mar;147(3):565-8.
Rifampin, a potent inducer of the hepatic microsomal system, has been shown to cause clinically important interactions when combined with other drugs, including oral anticoagulants, oral contraceptives, digitoxin, methadone hydrochloride, sulfonylureas, and barbiturates. Additional literature on previously described interactions has been published recently on quinidine, glucocorticoids, digoxin, and theophylline. New rifampin interactions have been described for cyclosporine, ketoconazole, chloramphenicol, beta-blockers, verapamil, and phenytoin. These interactions seem to be of clinical significance.
利福平是肝微粒体系统的强效诱导剂,已证明它与其他药物合用时会引起具有临床重要意义的相互作用,这些药物包括口服抗凝剂、口服避孕药、洋地黄毒苷、盐酸美沙酮、磺脲类药物和巴比妥类药物。最近已发表了关于先前描述的与奎尼丁、糖皮质激素、地高辛和茶碱相互作用的更多文献。还描述了利福平与环孢素、酮康唑、氯霉素、β受体阻滞剂、维拉帕米和苯妥英钠的新相互作用。这些相互作用似乎具有临床意义。